| Literature DB >> 26697389 |
J C Gomez-Verjan1, E A Estrella-Parra1, I Gonzalez-Sanchez1, N A Rivero-Segura2, R Vazquez-Martinez2, G Magos-Guerrero3, D Mendoza-Villanueva4, M A Cerbón-Cervantes2, R Reyes-Chilpa1.
Abstract
Calophyllum brasiliense (Calophyllaceae) is a tropical rain forest tree, mainly distributed in South and Central America. It is an important source of bioactive natural products like, for instance soulatrolide, and mammea type coumarins. Soulatrolide is a tetracyclic dipyranocoumarins and a potent inhibitor of HIV-1 reverse transcriptase and Mycobacterium tuberculosis. Mammea A/BA and A/BB coumarins, pure or as a mixture, are highly active against several leukemia cell lines, Trypanosoma cruzi and Leishmania amazonensis. In the present work, a toxicogenomic analysis of Soulatrolide and Mammea A/BA + A/BB (3:1) mixture was performed in order to validate the toxicological potential of this type of compounds. Soulatrolide or mixture of mammea A/BA + A/BB (3:1) was administered orally to male mice (CD-1) at dose of 100 mg/kg/daily, for 1 week. After this time, mice were sacrificed, and RNA extracted from the liver of treated animals. Transcriptomic analysis was performed using Affymetrix Mouse Gene 1.0 ST Array. Robust microarray analysis (RMA) and two way ANOVA test revealed for mammea mixture treatment 46 genes upregulated and 72 downregulated genes; meanwhile, for soulatrolide 665 were upregulated and 1077 downregulated genes. Enrichment analysis for such genes revealed that in both type of treatments genetic expression were mainly involved in drug metabolism. Overall results indicate a safety profile. The microarray data complies with MIAME guidelines and are deposited in GEO under accession number GSE72755.Entities:
Year: 2015 PMID: 26697389 PMCID: PMC4664773 DOI: 10.1016/j.gdata.2015.10.006
Source DB: PubMed Journal: Genom Data ISSN: 2213-5960
Analysis of pathways enriched by coumarins treatments (Soulatrolide 1744 DEG's and Mammea A/BA + A/BB-120 DEG's).
| Treatment/genes | Pathway | P-Value | Count |
|---|---|---|---|
| Mammea A/BA + A/BB (3:1) | KEGG_PATHWAY: | 4.96E-5 | 8 |
| KEGG_PATHWAY: | 0.00103 | 5 | |
| Mammea A/BA + A/BB (3:1) | KEGG_PATHWAY | 0.005272 | 4 |
| Soulatrolide | KEGG_PATHWAY | 3.36E-11 | 34 |
| KEGG_PATHWAY | 4.94E-10 | 38 | |
| KEGG_PATHWAY | 2.36E-8 | 52 | |
| Soulatrolide | KEGG_PATHWAY | 3.359E-11 | 34 |
| KEGG_PATHWAY | 4.94E-10 | 38 | |
| KEGG_PATHWAY | 2.36E-8 | 52 |
| Specifications | |
|---|---|
| Subject area | Chemistry |
| More specific subject area | Natural Products–Toxicogenomics |
| Organism/cell line/tissue | CD-1 mice |
| Sex | Male |
| Sequencer or array type | Affymetrix mouse gene chip 1.0 Array |
| Data format | Raw and Analyzed with RMA and two way ANOVA |
| Experimental factors | Comparison of control (SSI) and treatment (100 mg/Kg) with soulatrolide or mammea A/BA + A/BB (3:1) mixture |
| Experimental features | RNA was extracted from the liver of mice after 1 week of treatment, converted to cDNA and hybridized to Affymetrix arrays |
| Consent | All animal work was conducted in strict accordance with relevant national and international guidelines. The study protocol IG-2005-13 was approved by the Animal and Ethics Experiment Board of School of Medicine of Universidad Nacional Autónoma de México |
| Sample source location | Facultad de Medicina, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico. |